Aurigene Discovery Technologies (India)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 34 papers

  • Open Access
  • Research Article

Targeted HDAC8 inhibition with non-hydroxamate [1,2,4]triazolo[4,3-a] quinoline compounds.

  • Feb 20, 2026
  • Scientific reports
  • N V M Rao Bandaru +11
  • Open Access
  • Research Article

Chemical synthesis of novel aminopyrimidin-4-yl-1H-pyrazole derivatives as spleen tyrosine kinase (SYK) inhibitors.

  • Feb 11, 2026
  • Scientific reports
  • K V Rajasheker +12
  • Research Article
  • Citations1

Synthesis and characterization of a multifunctional new oxazole derivatives for enhanced steady state photoluminescence dynamics, phosphorescence decay characteristics and their DFT studies

  • Jan 01, 2026
  • Journal of Molecular Structure
  • Santosh Nandi +7
  • Open Access
  • Conference Article

288 Novel IL-15 modules promote long-term persistence, repeated tumor killing and self-sustenance of chimeric antigen receptor-natural killer (CAR-NK) cells manufactured using an indigenous platform

  • Nov 01, 2025
  • Regular and Young Investigator Award Abstracts
  • Devi Prasad Vijayashankar +6
  • Open Access
  • Research Article
  • Citations6

A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation

  • Apr 03, 2024
  • Journal of Allergy and Clinical Immunology: Global
  • Yuki Nakamura +11
  • Research Article

Abstract 4114: Evaluation of AU-18069, a novel small molecule CBP/p300 bromodomain inhibitor for the treatment of cancers

  • Jun 15, 2022
  • Cancer Research
  • Chandrasekhar Abbineni +28
  • Research Article
  • Citations2

Abstract 3500: AUR103 an oral small molecule CD47 antagonist in combination with azacytidine and bortezomib exhibits potent anti-tumor activity in myeloma and leukemia models <i>in vitro</i> and <i>in vivo</i>

  • Jun 15, 2022
  • Cancer Research
  • Girish C Daginakatte +14
  • Open Access
  • Research Article
  • Citations28

Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer

  • Mar 31, 2022
  • Molecular Cancer Therapeutics
  • Craig Furman +26
  • Open Access
  • Research Article

Importance of Pharmacokinetic Profiling &amp; Drug-Drug Interaction Evaluations in the Development of Complementary and Alternative Medicines

  • Dec 06, 2021
  • Advances in Complementary &amp; Alternative Medicine
  • Yeshwant Singh
  • Open Access
  • Research Article
  • Citations5

How to stop disproportionation of a hydrochloride salt of a very weakly basic compound in a non-clinical suspension formulation

  • Jul 15, 2021
  • International Journal of Pharmaceutics
  • Krista Ojala +11
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.